知镜 Cognispect · 医学文献与研究工作台

S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis.

Liu Y, Hu C, Luo S, Han Y, Li L, Wei L, Chen W, Yang M.
European journal of pharmacology · 2026-07-23 · PMID 42492881

文献摘要

Background Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with limited therapeutic options. S14G-humanin (HNG), a potent analog of humanin, exerts protective effects in various diseases, but its role in DN remains unexplored. Methods DN was induced in C57BL/6 mice via high-fat diet and streptozotocin (STZ), with or without HNG treatment. Renal injury, necroptosis, and Z-DNA/ZBP1 pathways were evaluated by histology, western blotting, and transcriptomics, and key findings were validated in db/db mice and high glucose/palmitate (HG + PA)-treated HK-2 cells. Results HNG treatment dose-dependently alleviated renal injury in DN mice. Specifically, high-dose-HNG significantly reduced the urinary albumin-to-creatinine ratio (UACR) by 49.5% (from 103.91 ± 7.68 to 52.50 ± 4.02 μg/mg, P Conclusion HNG ameliorates DN tubular injury by inhibiting BAX-driven mitochondrial oxidative stress and subsequent Z-DNA/ZBP1-mediated necroptosis, highlighting HNG as a promising therapeutic candidate for DN.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。